Aspen Aerogels, Inc.
ASPN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.55 | 0.34 | -0.04 | -0.52 |
| FCF Yield | -4.42% | -19.90% | -58.69% | -2.14% |
| EV / EBITDA | 17.44 | -49.08 | -4.70 | -56.34 |
| Quality | ||||
| ROIC | 5.95% | -7.85% | -14.50% | -20.22% |
| Gross Margin | 40.40% | 23.84% | 2.76% | 8.17% |
| Cash Conversion Ratio | 3.41 | 0.93 | 1.14 | 0.50 |
| Growth | ||||
| Revenue 3-Year CAGR | 35.90% | 25.21% | 21.62% | -4.44% |
| Free Cash Flow Growth | 81.33% | 19.94% | -740.50% | -142.92% |
| Safety | ||||
| Net Debt / EBITDA | -0.46 | 0.04 | 2.35 | 2.38 |
| Interest Coverage | 4.56 | -9.23 | -15.51 | -177.29 |
| Efficiency | ||||
| Inventory Turnover | 5.67 | 4.64 | 7.78 | 9.32 |
| Cash Conversion Cycle | 92.28 | 83.12 | 49.07 | 43.48 |